These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 33795384)

  • 1. Current strategies to circumvent the antiviral immunity to optimize cancer virotherapy.
    Shin DH; Nguyen T; Ozpolat B; Lang F; Alonso M; Gomez-Manzano C; Fueyo J
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33795384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncolytic viruses and immunity.
    Chaurasiya S; Chen NG; Fong Y
    Curr Opin Immunol; 2018 Apr; 51():83-90. PubMed ID: 29550660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating oncolytic viruses in combination cancer immunotherapy.
    Bommareddy PK; Shettigar M; Kaufman HL
    Nat Rev Immunol; 2018 Aug; 18(8):498-513. PubMed ID: 29743717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulation in Oncolytic Measles Virotherapy.
    Dietz L; Engeland CE
    Methods Mol Biol; 2020; 2058():111-126. PubMed ID: 31486034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lighting a Fire in the Tumor Microenvironment Using Oncolytic Immunotherapy.
    Achard C; Surendran A; Wedge ME; Ungerechts G; Bell J; Ilkow CS
    EBioMedicine; 2018 May; 31():17-24. PubMed ID: 29724655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic Immunotherapy for Treatment of Cancer.
    Tsun A; Miao XN; Wang CM; Yu DC
    Adv Exp Med Biol; 2016; 909():241-83. PubMed ID: 27240460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy.
    Zhang B; Cheng P
    Mol Cancer; 2020 Nov; 19(1):158. PubMed ID: 33172438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune recruitment and therapeutic synergy: keys to optimizing oncolytic viral therapy?
    Naik JD; Twelves CJ; Selby PJ; Vile RG; Chester JD
    Clin Cancer Res; 2011 Jul; 17(13):4214-24. PubMed ID: 21576084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic viruses for induction of anti-tumor immunity.
    Tong AW; Senzer N; Cerullo V; Templeton NS; Hemminki A; Nemunaitis J
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1750-60. PubMed ID: 21740355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of NK cells in immunotherapy and virotherapy of solid tumors.
    Cantoni C; Grauwet K; Pietra G; Parodi M; Mingari MC; De Maria A; Favoreel H; Vitale M
    Immunotherapy; 2015; 7(8):861-82. PubMed ID: 26314197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Conversion of Tumor Microenvironment by Oncolytic Viruses: The Protoparvovirus H-1PV Case Study.
    Marchini A; Daeffler L; Pozdeev VI; Angelova A; Rommelaere J
    Front Immunol; 2019; 10():1848. PubMed ID: 31440242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination of Oncolytic Virotherapy and CAR T/NK Cell Therapy for the Treatment of Cancer].
    Kochneva GV; Sivolobova GF; Tkacheva AV; Gorchakov AA; Kulemzin SV
    Mol Biol (Mosk); 2020; 54(1):3-16. PubMed ID: 32163385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using oncolytic viruses to ignite the tumour immune microenvironment in bladder cancer.
    Li R; Zhang J; Gilbert SM; Conejo-Garcia J; Mulé JJ
    Nat Rev Urol; 2021 Sep; 18(9):543-555. PubMed ID: 34183833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidirectional Strategies for Targeted Delivery of Oncolytic Viruses by Tumor Infiltrating Immune Cells.
    Osali A; Zhiani M; Ghaebi M; Meymanat M; Esmaeilzadeh A
    Pharmacol Res; 2020 Nov; 161():105094. PubMed ID: 32795509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic virotherapy as immunotherapy.
    Melcher A; Harrington K; Vile R
    Science; 2021 Dec; 374(6573):1325-1326. PubMed ID: 34882456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune landscape and response to oncolytic virus-based immunotherapy.
    Lin C; Teng W; Tian Y; Li S; Xia N; Huang C
    Front Med; 2024 Jun; 18(3):411-429. PubMed ID: 38453818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncolytic Viral Therapy and the Immune System: A Double-Edged Sword Against Cancer.
    Marelli G; Howells A; Lemoine NR; Wang Y
    Front Immunol; 2018; 9():866. PubMed ID: 29755464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncolytic viruses for cancer immunotherapy.
    Hemminki O; Dos Santos JM; Hemminki A
    J Hematol Oncol; 2020 Jun; 13(1):84. PubMed ID: 32600470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Immunological Treatment Effects of Virotherapy in Tumor Tissue.
    Das K; Urbiola C; Spiesschaert B; Mueller P; Wollmann G
    Methods Mol Biol; 2020; 2058():155-177. PubMed ID: 31486037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Multifaceted Role of Macrophages in Oncolytic Virotherapy.
    Hofman L; Lawler SE; Lamfers MLM
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.